-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A study by Karolinska Institutet in Sweden showed that young breast cancer patients do not increase the risk
About one in ten breast cancer patients are of childbearing age and are at risk
Anna Marklund, from the Department of Oncology Pathology at Karolinska Institutet, said: "It is not uncommon
In the study, researchers at The Karolinska Institutet investigated whether fertility preservation regimens associated with breast cancer diagnosis increased the risk of
The study covered 1,275 women of childbearing age in Sweden who were treated
Women who underwent fertility preservation surgery matched
Within five years, 89 percent of breast cancer patients who received ovarian hormone stimulation did not relapse, 83 percent of patients who received ovarian tissue freezing, and 82 percent
After five years of breast cancer treatment, patients who received hormone stimulation to freeze eggs or embryos survived 96 percent, fertility preservation surgery without hormone stimulation, and 90 percent
Corresponding author Kenny Rodriguez-Wallberg, adjunct professor in the Department of Oncology Pathology at Karolinska Institutet, said: "We did not find an increased
Currently, the researchers plan to follow up on the findings
Search for the original text
Anna Marklund, Tobias Lekberg, Elham Hedayati, Annelie Liljegren, Jonas Bergh, Frida E.
